Avid Bioservices Announces Appointment of Magnus Schroeder,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
471
Avid Bioservices Announces Appointment of Magnus Schroeder, Ph.D., as Vice President of Process Sciences

-- Addition of Senior Executive with Significant Process Science Experience Supports Company’s Efforts to Expand and Enhance Process Development Capabilities --

TUSTIN, Calif., May 08, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced the appointment of Magnus Schroeder, Ph.D., as vice president of process sciences. Dr. Schroeder is an accomplished scientist with more than 16 years of experience spanning bioprocess development, cGMP manufacturing, CMC strategy and global project leadership.  In his new role, he will be responsible for overseeing Avid’s process sciences function, including the development of compliant, robust and scalable processes, implementation of state-of-the-art, high-throughput process development technologies, and efficient “on-boarding” of new client programs.  As part of these efforts, Dr. Schroeder will directly manage the company’s technology collaborations, as well as its completion of development of its novel CHO-based mammalian expression system.

Dr. Schroeder most recently served as a director at AGC Biologics, formerly CMC Biologics, a global contract development and manufacturing organization, where he participated in the successful commercial launch of multiple products.  In that role, he successfully supported more than 25 client projects as they progressed toward first-in-human clinical trials, commercial product launch and ongoing commercial supply.  These efforts included creative resolution of complex challenges related to commercial processes that directly impacted a range of regulatory interactions and filings.  In directing AGC’s purification development team, Dr. Schroeder oversaw early-to-late phase development, process characterization, process control strategy, commercial process support and technology transfer/facility fit activities.  Prior to AGC Biologics, Dr. Schroeder held multiple senior level positions with CSL Limited, a global leader in the field of biotechnology.  During his tenure, he served as senior manager and senior scientist, leading process development activities for a range of CSL’s innovative biologics.  He has also held key process science positions with Dynavax Technologies, in which he was responsible for supporting process development, characterization and validation for multiple programs.  Dr. Schroeder earned his Ph.D. in biochemical engineering and his master of science in molecular biotechnology from Bielefeld University in Bielefeld, Germany.  He has previously served as a visiting scientist for protein purification at Rensselaer Polytechnic Institute and a visiting scientist for cell culture engineering at the University of Minnesota.

“As we continue to strategically increase our focus on process development to best align with industry needs, we have prioritized supplementing our in-house process science talent.  With Magnus joining our team as vice president of process sciences, we have significantly strengthened the company’s expertise in this critical area, positioning us to continue to deliver our customers industry-leading service and results,” said Roger Lias, Ph.D., Avid’s president and chief executive officer. “Importantly, we believe that the innovative process development insights and approaches that Magnus is bringing to Avid will further support our new customer acquisition efforts by highlighting additional unique competitive advantages that we can offer companies with biopharmaceutical development and manufacturing needs.”

About Avid Bioservices, Inc. Avid Bioservices is a dedicated contract development and manufacturing organization (CDMO) focused on development and cGMP manufacturing of biopharmaceutical products derived from mammalian cell culture.  The company provides a comprehensive range of process development, high quality cGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries.  With 25 years of experience producing monoclonal antibodies and recombinant proteins in batch, fed-batch and perfusion modes, Avid's services include cGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory strategy, submission and support.  The company also provides a variety of process development activities, including cell line development and optimization, cell culture and feed optimization, analytical methods development and product characterization.  www.avidbio.com

Contacts:
Stephanie Diaz (Investors)                                      
Vida Strategic Partners                                   
415-675-7401                                                                                                                          
sdiaz@vidasp.com                                           

Tim Brons (Media)
Vida Strategic Partners 
415-675-7402
tbrons@vidasp.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Alphabet Lawsuit Puts Gemini Delays Under a Microscope

Updated Category News Views 189

July’s twin punches to Alphabet shares were not the sort of wobble investors can casually shrug off. First came a report on July 16 that Google was months behind on Gemini 3.5 Pro, its flagship AI model, after disappointing results from updated training data. Then came the harder financial reality a week later: a much larger 2026 capital-spending plan, negative...

Continue Reading
Cybersecurity's AI Tailwind Meets a Brutal Market Test

Updated Category News Views 89

Security software caught a bid while the rest of the tape was getting kicked down the stairs. That contrast is the whole story: investors saw Palo Alto Networks deliver a strong fiscal first quarter and raise its fiscal 2027 outlook, then decided cyber defense may be one of the few technology budgets companies cannot casually postpone. With AI helping attackers locate and...

Continue Reading
Label-Free Detection Has a Solid, Narrow Growth Lane

Updated Category News Views 77

Biologics labs are turning into a far better hunting ground for analytical equipment than the old, broad-brush research story suggests. Label-free detection is not a giant market, and nobody should dress it up as one. But the projected move from $0.58 billion in 2026 to $0.85 billion by 2031 points to a useful 8.1% annual growth lane, driven by work researchers genuinely...

Continue Reading
ECW Puts $52 Million Behind Learning Through Crisis

Updated Category News Views 0

A reserve fund for a classroom is not glamorous, but it may be the smartest detail in this whole $52 million commitment. Education Cannot Wait has announced support for more than 300,000 children in Lebanon, Myanmar and South Sudan, where war, flooding and displacement have ripped ordinary schooling apart. The money is meant to restore learning, provide catch-up classes...

Continue Reading
JDEnergy's RE+ Push Meets a Grid Hungry for Storage

Updated Category News Views 107

Certification Is Useful, Not a Victory Lap A battery box earning a safety certificate is not usually thrilling stuff, but the timing matters here. On Nov. 19, 2026, JDEnergy laid out its North American storage pitch at RE+ in Las Vegas while electricity demand is getting shoved higher by industrial buildout and AI data centers. Add more variable renewable generation to an...

Continue Reading
Palmer Holland Takes Natural Colors Across North America

Updated Category News Views 71

Natural food color sounds like a tidy little ingredient story until somebody tries to keep a blue beverage blue on a retail shelf. That is where Palmer Holland's new exclusive North American commercial arrangement with BOTANIKind gets interesting. This is not a flashy public-market transaction, and neither company has handed investors a revenue figure, volume target, or...

Continue Reading
NEWWAVE Turns 15 and Chases a Bigger Tech Partner Role

Updated Category News Views 97

Fifteen years is about when an outsourced engineering shop has to prove it can be more than extra hands on a keyboard. NEWWAVE’s new identity and “Trusted Technology Partner” positioning are an attempt to make that jump: from carrying out software work to helping clients decide what work ought to be done, then sticking around after launch. It is a sensible ambition,...

Continue Reading
CITGO Sign Return Caps Kenmore's Careful Rebuild Work

Updated Category News Views 0

Thirty feet upward and 120 feet eastward is not the sort of move that usually stops a city in its tracks, yet Boston’s CITGO Sign was never merely rooftop hardware. Its public relighting in Kenmore Square marks the final phase of the redevelopment at 660 Beacon Street, and the real accomplishment is less flashy than the lights: a beloved, federally landmarked object...

Continue Reading
AMP Pushes Debt Wall to 2029 With €1.3B Green Notes

Updated Category News Views 0

A Refinancing With Some Actual Breathing Room Metal cans may be boring, but a debt wall arriving in 2028 is not—and Ardagh Metal Packaging has moved that problem down the road. AMP priced €1.3 billion of senior secured floating-rate green notes on November 20, 2026. The proceeds are earmarked to redeem $600 million of senior secured green notes due in 2028 and €450...

Continue Reading
Zesty Takes Kubernetes Cost Control Into GPU Territory

Updated Category News Views 88

GPU waste has become the sort of cloud bill nobody wants to explain upstairs. A company buys scarce, expensive accelerators for AI work, then discovers that real workloads do not politely consume resources in neat, permanent blocks. Demand jumps, memory needs shift, and somebody either over-allocates to avoid trouble or under-allocates and gets ugly out-of-memory...

Continue Reading

Top 5 Most Recently Viewed Articles

The ONE Group Sees Impressive Q4 Revenue Growth Surge

Updated Category News Views 171

The ONE Group Reports Impressive Revenue Growth In an exciting turn of events, The ONE Group Hospitality (NASDAQ: STKS) has reported significant revenue growth in its most recent quarter. The company attributes its success to a robust expansion strategy and key acquisitions that boosted its market presence. Quarterly Performance Overview Despite the overall revenue surge,...

Continue Reading
Garnier's Water Works Revolutionizes Skincare with Reality Drama

Updated Category News Views 458

Garnier's Innovative Water Works Campaign Garnier is taking bold steps in the skincare industry with the launch of their latest initiative, the "Water Works" campaign. This compelling campaign ingeniously combines the high-drama moments of reality television with skincare, particularly focusing on the brand's renowned Waterproof Micellar Water. Iconic Reality TV Moments...

Continue Reading
IGT's Comprehensive Showcase of Gaming Innovations in 2025

Updated Category News Views 240

IGT’s Comprehensive Showcase at Global Gaming Expo 2025 IGT is all set to demonstrate its extraordinary capabilities at the Global Gaming Expo 2025. This year's event promises to be monumental, highlighting IGT's innovative prowess in the realms of gaming, digital solutions, and financial technology, also referred to as FinTech. Theme and Presentation Highlights The...

Continue Reading
Four Companies Boost 2025 Guidance Encouraging Analyst Revisions

Updated Category News Views 579

Positive Earnings Results Lead to Upgraded Guidance A significant wave of guidance upgrades from major companies is reshaping the outlook for 2025, driving analyst target revisions. Robust Q2 earnings have led several prominent firms to revise their forecasts for the year, triggering an array of price target adjustments across the market. This uptick in guidance is not...

Continue Reading
Investec's Disclosure of De La Rue plc Trading Activities

Updated Category News Views 179

Overview of Recent Trading Activities As part of its commitment to transparency and adhering to the Takeover Code, Investec Bank plc disclosed its trading activities related to De La Rue plc. This public dealing disclosure is significant as it provides insights into the trading behavior in the market, especially pertaining to a company that plays a crucial role in the...

Continue Reading